Latest Articles

Publication Date
ACC healthcare harm claims rejected at 26 times rate of standard claims - The Press

ACC healthcare harm claims rejected at 26 times rate of standard claims The Press

Published: June 1, 2026, 4 p.m.
Democrat Congresswoman Wants 12 Days Paid Leave to Kill Babies in Abortions - lifenews.com

Democrat Congresswoman Wants 12 Days Paid Leave to Kill Babies in Abortions lifenews.com

Published: June 1, 2026, 3 p.m.
Your Period Shouldn鈥檛 Ruin Your Week: Why Gen Z Gals Need to Rethink Menstrual Pain - ETV Bharat

Your Period Shouldn鈥檛 Ruin Your Week: Why Gen Z Gals Need to Rethink Menstrual Pain ETV Bharat

Published: June 1, 2026, 8:31 a.m.
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive

Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive

Published: May 30, 2026, 9:59 p.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive

Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive

Published: May 30, 2026, 12:24 a.m.
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org

Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org

Published: May 29, 2026, 11:56 p.m.
馃敶 Crohns disease and ulcerative colitis are among the list of confirmed conditions - facebook.com

馃敶 Crohns disease and ulcerative colitis are among the list of confirmed conditions facebook.com

Published: May 29, 2026, 11:35 p.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork

Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork

Published: May 29, 2026, 10:40 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology

Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology

Published: May 29, 2026, 10:11 p.m.
Olympia Quir贸nsalud urges women not to consider symptoms that can be treated as normal - Dem贸crata

Olympia Quir贸nsalud urges women not to consider symptoms that can be treated as normal Dem贸crata

Published: May 28, 2026, 3:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!